Pediatric Gliomas as Cellular Identity Disorders

Cancer dynamics and complexity are increasingly understood as disruptions of collective cellular intelligence. Pediatric gliomas, in particular, exhibit aberrant cell fate decisions driven by plasticity networks, a hallmark of cybernetic dysregulation and stalled developmental processes. These malignancies reflect a breakdown in systemic cell communication and identity resolution, wherein glioma cells become trapped in unstable, transitional attractor states, unable to commit to terminal differentiation. Consequently, they exhibit maladaptive behaviors such as therapy resistance, invasion, and cellular heterogeneity. Using complex systems approaches, our recent single-cell transcriptomic analyses reveal that these behaviors emerge from network plasticity signatures—many of which are also implicated in neuropsychiatric and neurodevelopmental disorders.This identity disorder perspective opens a behavioral paradigm to cancer ecologies, and therapeutic window, not solely to eradicate cancer cells, as the 'disease', but to understand their "umwelt", and redirect them towards systemic re-integration akin to contemporary psychotherapeutic principles and trauma-informed care. Differentiation therapy—and related systems medicine strategies such as cell fate reprogramming and ecosystem engineering, aim to restore disrupted developmental trajectories. These approaches seek to redirect cancer cells toward their favored lineage commitments, revealing an underlying teleonomy within their attractor landscapes. In this perspective, we propose that by targeting the unstable attractor dynamics and network-based regulatory hubs driving phenotypic plasticity, the amalgamation of precision psychiatry and systems oncology may repair the fragmented tumor ecosystem, resolving their underlying identity crisis, and reintegrating cancer cells toward physiological coherence.